Tirzepatide route of administration: what you're actually deciding

Tirzepatide is injected subcutaneously (under the skin) once a week, not into a vein or muscle.
Three licensed injection sites: abdomen, outer thigh, and upper arm — rotated weekly to protect the skin.
The Mounjaro KwikPen contains four weekly doses, so one pen lasts a full month at a single dose level.
No mixing, no drawing up: the pen is pre-filled and pre-set, with a hidden needle that retracts after each use.

Tirzepatide is given as a subcutaneous injection — a small, once-weekly shot delivered just under the skin, using a pre-filled pen. That single fact shapes almost every practical question about Mounjaro: where to inject, how to rotate sites, and whether the method suits you. Understanding the route of administration helps you decide whether this treatment fits your life before you speak to a prescriber. As a prescription-only medicine, tirzepatide requires a clinical assessment; a prescriber judges whether it is appropriate for you personally.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Everything that shapes the injection decision, site, technique, timing and what changes at each dose

Why the injection route was chosen over a tablet

Tirzepatide is a large peptide molecule. Taken orally, it would be broken down in the stomach before reaching the bloodstream in useful amounts, a problem the drug's designers solved by delivering it subcutaneously instead. The fatty tissue just under the skin absorbs the molecule steadily, producing a smooth weekly concentration curve rather than peaks and troughs. That slow-release profile is part of why once-weekly dosing works.

If the idea of injecting yourself gives you pause, that reaction is common. Most people find the Mounjaro KwikPen considerably less confronting in practice than the word "injection" implies. The needle is short, fine, and concealed in the pen tip; you press the pen against the skin, press the button, and it is done. Our clinical team hear this regularly: the anticipation is almost always worse than the act. The step-by-step administration video shows exactly what happens, which helps.

The subcutaneous route also means no clinic visit. You inject at home, at a time that suits you, many people find a fixed day easier to remember, the same way you might take a weekly tablet.

Which sites you can use, and why rotation matters

The three licensed injection sites for tirzepatide are the abdomen (avoiding the two-inch area around the navel), the outer thigh, and the upper arm. Rotating between them week to week is not just a recommendation to observe in theory; repeated injections into the same small area can cause lipohypertrophy, a thickening of fatty tissue that slows absorption and can affect how well the medicine works. The full administration instructions cover the spacing rules in detail.

A few practical points that often come up. Injecting into the abdomen is the easiest site to self-administer; the thigh works well too. Upper-arm injections are straightforward if someone else is administering, or you have enough reach. Skin should be clean and dry; the injection site should be at room temperature. Alcohol swabs are optional but fine to use if you prefer them, let the skin dry before injecting.

It is worth noting that injection site choice can interact with timing. If you exercise intensively shortly after an injection, blood flow to muscle tissue increases, and the Society for Endocrinology notes that peripheral circulation changes can theoretically affect subcutaneous absorption, though in practice this is rarely clinically significant. Check with your prescriber if you train hard on injection days. Detailed Mounjaro administration guidance covers these edge cases.

What changes as the dose increases

Tirzepatide is started at 2.5 mg for the first four weeks. That lower starting dose exists to let your system adjust to the medicine gradually, gastrointestinal side effects such as nausea, burping, and loose stools are most likely in the first few weeks and tend to settle. The dose is then increased, typically in 4-week steps, by a prescriber who reviews your response and tolerance. The licensed UK strengths run from 2.5 mg up to 15 mg.

The route of administration itself does not change as the dose increases. You are still injecting subcutaneously once a week, at the same three site options, with the same pen design. What changes is the volume delivered and the strength of the formulation. Each KwikPen contains four weekly doses, so ordering at a specific dose level means one pen covers a calendar month. Questions about which dose is right for you belong with your prescriber, the tirzepatide overview page explains the clinical context, and the prescribers at our clinical team review every consultation personally.

For a broader look at how treatment fits into weight management, the weight-loss treatment overview is a useful starting point. If you are also considering cost as part of your decision, what to expect when accessing Mounjaro privately sets out what a legitimate service includes in its price. The NHS tirzepatide patient information on the NHS medicines page is the clearest official summary of how the medicine is given and what to watch for.

Practical storage and the window before injecting

Tirzepatide pens are stored in the fridge at 2–8 °C. Before injecting, you can let the pen sit at room temperature briefly, but the exact window for this, and whether you can use a pen that has been out longer than intended, is specified in the Patient Information Leaflet rather than something to estimate. Always defer to the leaflet or your prescriber on storage questions; the Mounjaro Summary of Product Characteristics on the eMC is the authoritative source.

One thing worth planning ahead: if you order by 12 pm on a weekday, once clinical approval is in place the pen is dispatched the same day and arrives with DPD the following working day, in plain packaging. Keeping an eye on your fridge space before the delivery arrives is a small but useful habit. If you have questions about your technique after starting, our aftercare team is available seven days a week. A practical guide to administering Mounjaro covers common questions about what to do if you press the wrong site or the pen clicks but nothing happens.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions